Reports for MYLAN PHARMACEUTICALS ULC
Formerly known as UPJOHN CANADA ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-04-15 | 2025-04-23 | 255076 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-03-17 | 2021-04-19 | 135792 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2020-09-30 | 2020-09-30 | 125302 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-01-15 | 2025-02-19 | 247737 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2024-11-06 | 2025-03-26 | 242126 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-12-21 | 2022-01-04 | 151663 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-07-20 | 2022-09-07 | 165092 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-07-02 | 2020-10-01 | 119316 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-10-03 | 2024-01-10 | 205932 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2020-10-15 | 2020-11-03 | 126401 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-01-10 | 2023-02-14 | 180349 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-10-15 | 2021-03-17 | 126398 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-31 | 2023-08-29 | 193442 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2019-06-04 | 2019-06-18 | 85554 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-10-19 | 2023-01-10 | 172186 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-12-19 | 2024-01-16 | 213764 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-12-01 | 2021-02-03 | 129187 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-02-19 | 2025-04-15 | 250703 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-01 | 2023-08-29 | 191357 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-29 | 217867 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51624 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51618 |
| MYLAN-TELMISARTAN HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6819 |
| MYLAN-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6814 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Discontinued | 2017-04-13 | 2018-02-15 | 6822 |
| MYLAN-VALSARTAN | 40MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20209 |
| MYLAN-VALSARTAN | 160MG | TABLET | Discontinued | 2017-08-24 | 2017-11-02 | 20284 |
| MYLAN-VALSARTAN | 80MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44919 |
| MYLAN-VALSARTAN | 320MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20217 |
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6841 |
| MYLAN-VALSARTAN HCTZ | 25MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6836 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6833 |